Jn. Geiger et al., mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development, BLOOD, 97(4), 2001, pp. 901-910
DYRKs are a new subfamily of dual-specificity kinases that was originally d
iscovered on the basis of homology to Yak1, an inhibitor of cell cycle prog
ression in yeast. At present, mDYRK-3 and mDYRK-2 have been cloned, and mDY
RK-3 has been characterized with respect to kinase activity, expression amo
ng tissues and hematopoietic cells, and possible function during erythropoi
esis, In sequence, mDYRK-3 diverges markedly in noncatalytic domains from m
DYRK-2 and mDYRK-1a, but is 91.3% identical overall to hDYRK-3. Catalytical
ly, mDYRK-3 readily phosphorylated myelin basic protein (but not histone 2B
) and also appeared to autophosphorylate in vitro. Expression of mDYRK-1a,
mDYRK-2, and mDYRK-3 was high in testes, but unlike mDYRK1a and mDYRK 2, mD
YRK-3 was not expressed at appreciable levels in other tissues examined. Am
ong hematopoietic cells, however, mDYRK-3 expression was selectively elevat
ed in erythroid cell lines and primary pro-erythroid cells. In developmenta
lly synchronized erythroid progenitor cells, expression peaked sharply foll
owing exposure to erythropoietin plus stem cell factor (SCF) (but not SCF a
lone), and in situ hybridizations of sectioned embryos revealed selective e
xpression of mDYRK-3 in fetal liver. Interestingly, antisense oligonucleoti
des to mDYRK-3 were shown to significantly and specifically enhance colony-
forming unit-erythroid colony formation. Thus, it is proposed that mDYRK-3
kinase functions as a lineage-restricted, stage-specific suppressor of red
cell development. (C) 2001 by The American Society of Hematology.